Cochrane Clinical Answers - Access Denied - How does recombinant human erythropoietin compare with placebo/no treatment in people with anemia of chronic kidney disease who do not require dialysis?

Question:How does recombinant human erythropoietin compare with placebo/no treatment in people with anemia of chronic kidney disease who do not require dialysis?

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer evaluates recombinant human erythropoietin in people with anemia of chronic kidney disease.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.